Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$6.04
+0.5%
$5.88
$3.75
$9.40
$27.11M1.5327,944 shs16,552 shs
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
$11.47
+2.4%
$15.04
$10.17
$55.00
$3.79M-11.0744,635 shs32,036 shs
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$1.37
-0.7%
$1.44
$1.09
$2.73
$428.63M2.356.19 million shs3.83 million shs
10x Genomics stock logo
TXG
10x Genomics
$30.59
+4.8%
$24.05
$10.12
$35.65
$3.70B2.122.93 million shs3.28 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
+0.50%-6.50%-12.34%+19.11%+8.19%
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
+0.70%-18.94%-9.61%-23.54%-68.99%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-0.72%-13.29%-2.84%+1.48%+14.17%
10x Genomics stock logo
TXG
10x Genomics
+4.83%-0.39%+41.62%+49.51%+203.17%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$6.04
+0.5%
$5.88
$3.75
$9.40
$27.11M1.5327,944 shs16,552 shs
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
$11.47
+2.4%
$15.04
$10.17
$55.00
$3.79M-11.0744,635 shs32,036 shs
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$1.37
-0.7%
$1.44
$1.09
$2.73
$428.63M2.356.19 million shs3.83 million shs
10x Genomics stock logo
TXG
10x Genomics
$30.59
+4.8%
$24.05
$10.12
$35.65
$3.70B2.122.93 million shs3.28 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
+0.50%-6.50%-12.34%+19.11%+8.19%
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
+0.70%-18.94%-9.61%-23.54%-68.99%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-0.72%-13.29%-2.84%+1.48%+14.17%
10x Genomics stock logo
TXG
10x Genomics
+4.83%-0.39%+41.62%+49.51%+203.17%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
2.00
Hold$6.00-0.66% Downside
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
0.00
N/AN/AN/A
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
1.80
Reduce$1.8333.82% Upside
10x Genomics stock logo
TXG
10x Genomics
2.20
Hold$23.17-24.27% Downside

Current Analyst Ratings Breakdown

Latest PACB, TXG, HBIO, and LMNX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/18/2026
10x Genomics stock logo
TXG
10x Genomics
DowngradeStrong-BuyHold
5/12/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetEqual Weight$20.00 ➝ $22.00
5/12/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetNeutral$17.00 ➝ $20.00
5/11/2026
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
Boost Price TargetUnderweight$1.00 ➝ $1.50
4/21/2026
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
Reiterated RatingSell (E+)
4/20/2026
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
DowngradeStrong-BuyHold
4/20/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetBuy$22.00 ➝ $32.00
4/20/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetNeutral$21.00 ➝ $30.00
4/17/2026
10x Genomics stock logo
TXG
10x Genomics
UpgradeHoldStrong-Buy
4/14/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetOverweight$22.00 ➝ $30.00
4/14/2026
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
Lower Price TargetUnderweight$1.50 ➝ $1.00
(Data available from 6/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$86.55M0.31$11.84 per share0.51$3.07 per share1.97
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
$437.66M0.01$0.35 per share32.98$11.13 per share1.03
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$160.01M2.66$0.78 per share1.75$0.02 per share68.50
10x Genomics stock logo
TXG
10x Genomics
$642.82M6.04N/AN/A$6.24 per share4.90
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-$56.70M-$2.17N/AN/AN/A-11.44%-25.78%-4.37%8/10/2026 (Estimated)
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
$15.17M$0.5122.499.56N/A5.39%4.66%2.91%N/A
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-$546.38M-$0.43N/AN/AN/A-80.35%-571.06%-18.82%8/3/2026 (Estimated)
10x Genomics stock logo
TXG
10x Genomics
-$43.54M-$0.17N/AN/AN/A-3.55%-2.86%-2.23%8/6/2026 (Estimated)

Latest PACB, TXG, HBIO, and LMNX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2026Q1 2026
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-$0.62-$0.33+$0.29-$0.77$21.20 million$20.76 million
5/7/2026Q1 2026
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-$0.17-$0.12+$0.05-$0.03$39.94 million$37.18 million
5/7/2026Q1 2026
10x Genomics stock logo
TXG
10x Genomics
-$0.29-$0.10+$0.19-$0.10$146.41 million$150.84 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
N/AN/AN/AN/AN/A
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
$0.403.49%N/A78.43%N/A
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
N/AN/AN/AN/AN/A
10x Genomics stock logo
TXG
10x Genomics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
3.60
1.99
1.06
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
0.52
8.37
6.08
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
N/A
5.65
4.87
10x Genomics stock logo
TXG
10x Genomics
N/A
5.90
5.42
CompanyEmployeesShares OutstandingFree FloatOptionable
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
4904.51 million3.59 millionOptionable
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
1,325330,000N/AOptionable
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
730310.60 million299.11 millionOptionable
10x Genomics stock logo
TXG
10x Genomics
1,240126.96 million115.73 millionOptionable

Recent News About These Companies

10x Genomics buys Proteintech Genomics

New MarketBeat Followers Over Time

Media Sentiment Over Time

Harvard Bioscience stock logo

Harvard Bioscience NASDAQ:HBIO

$6.04 +0.03 (+0.50%)
Closing price 06/9/2026 04:00 PM Eastern
Extended Trading
$6.16 +0.13 (+2.07%)
As of 06/9/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Defiance Daily Target 2X Long LMND ETF stock logo

Defiance Daily Target 2X Long LMND ETF NASDAQ:LMNX

$11.47 +0.27 (+2.41%)
As of 06/9/2026 03:53 PM Eastern

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays. The company also provides xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism; ARIES system, a sample to answer real-time PCR platform; SYNCT data management software solutions; and ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 Assay, ARIES Flu A/B & RSV Assay, ARIES Group B Streptococcus Assay, ARIES Group A Strep Assay, ARIES Bordetella Assay, ARIES Norovirus Assay, ARIES C. difficile Assay, ARIES MRSA Assay, and SARS-CoV-2 Assay. In addition, it offers VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; VERIGENE test cartridges; Amnis FlowSight imaging flow cytometers; Amnis ImageStream Mark II imaging flow cytometers; Amnis CellStream for cell and particle analysis; Guava easyCyte benchtop flow cytometers; Muse cell analyzers; and IDEAS, an image analysis software. Luminex Corporation was founded in 1995 and is based in Austin, Texas.

Pacific Biosciences of California stock logo

Pacific Biosciences of California NASDAQ:PACB

$1.37 -0.01 (-0.72%)
Closing price 06/9/2026 04:00 PM Eastern
Extended Trading
$1.38 +0.01 (+1.09%)
As of 06/9/2026 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

10x Genomics stock logo

10x Genomics NASDAQ:TXG

$30.59 +1.41 (+4.83%)
Closing price 06/9/2026 04:00 PM Eastern
Extended Trading
$30.80 +0.21 (+0.69%)
As of 06/9/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.